Animate Biosciences Inc.’s lead therapeutic peptide MBb32 produced a significant reduction in cardiac scar tissue and subsequent recovery of heart function in a mouse model of severe myocardial injury ...
SAN FRANCISCO, February 19, 2026--(BUSINESS WIRE)--Animate Biosciences, a biotechnology company focused on designing innovative peptide therapeutics, today announces positive preclinical results ...
Single-dose designed peptide drives structural and functional cardiac repair in a mouse myocardial infarction model SAN FRANCISCO--(BUSINESS WIRE)--Animate Biosciences, a biotechnology company focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results